Browsing by Author Slee, Mark

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)Citation
2013The Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platformBarnett, Michael; Vucic, Steve; Butzkueven, Helmut; Jokubaitis, Vilija; Lechner-Scott, Jeanette; Liew, D; Shaw, C; Slee, Mark; Spelman, Timothy; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead)The Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platform, PLoS One, vol.8, 3, 2013,pp 1-9
2014The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of diseaseBarnett, Michael; Booth, David; Gatt, Prudence; Henderson, Andrew Patrick David; McKay, Fiona Catherine; Parnell, Grant; Schibeci, Stephen; Stewart, Graeme; Vucic, Steve; Baranzini, Sergio; Batten, Marcel L; Dorothee, Nickles; Krupa, Malgorzata; Slee, Mark; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Medicine; Western Clinical School: Westmead Millennium Institute; Nepean Clinical School: Medicine; Medicine; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease, Clinical Immunology, vol.151, 1, 2014,pp 16-24
2016Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: A propensity score-matched studyBarnett, Michael; Alroughani, Raed; Duquette, P; et al, Various; Grammond, Pierre; Grand' Maison, Francois; Kister, Ilya; Lechner-Scott, Jeannette; Lugaresi, Alessandra; Slee, Mark; Spelman, Timothy; Central Clinical School: Inst. of Clinical NeurosciencesDiscontinuing disease-modifying therapy in MS after a prolonged relapse-free period: A propensity score-matched study, Journal of Neurology, Neurosurgery and Psychiatry, vol.87, 10, 2016,pp 1133-1137
2016Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: A propensity score-matched studyBarnett, Michael; Alroughani, Raed; Duquette, P; et al, Various; Grammond, Pierre; Grand' Maison, Francois; Kister, Ilya; Lechner-Scott, Jeannette; Lugaresi, Alessandra; Slee, Mark; Spelman, Timothy; Central Clinical School: Inst. of Clinical NeurosciencesDiscontinuing disease-modifying therapy in MS after a prolonged relapse-free period: A propensity score-matched study, Journal of Neurology, Neurosurgery and Psychiatry, vol.87, 10, 2016,pp 1133-1137
2014Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by seasonBooth, David; Gatt, Prudence; Liddle, Christopher; McKay, Fiona Catherine; Parnell, Grant; Schibeci, Stephen; Stewart, Graeme; Vucic, Steve; Broadley, Simon; Krupa, Malgorzata; Lechner-Scott, Jeannette; Montgomery, Grant; Powell, Jospeh; Slee, Mark; Visscher, Peter; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Nepean Clinical School: Medicine; Medicine; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season, Multiple Sclerosis Journal, vol.20, 6, 2014,pp 675-685
2014Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapiesBarnett, Michael; Heard, Robert; Parratt, John Douglas; Pollard, John; Reddel, Stephen; Spies, Judith; Boggild, Mike; Brew, B.J. (Bruce); Broadley, Simon; Butzkueven, Helmut; et al, Various; Hodgkinson, Suzanne J.; Kermode, Allan; Lechner-Scott, Jeannette; Macdonell, Richard A.L.; Marriott, Mark; Mason, Deborah F.; Shaw, Cameron P.; Slee, Mark; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineTherapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies, Journal of Clinical Neuroscience, vol.21, 11, 2014,pp 1835-1846
2014Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacyBarnett, Michael; Heard, Robert; Parratt, John Douglas; Pollard, John; Reddel, Stephen; Spies, Judith; Boggild, Mike; Brew, B.J. (Bruce); Broadley, Simon; Butzkueven, Helmut; et al, Various; Hodgkinson, Suzanne J.; Kermode, Allan; Lechner-Scott, Jeannette; Macdonell, Richard A.L.; Marriott, Mark; Mason, Deborah F.; Shaw, Cameron P.; Slee, Mark; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineTherapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy, Journal of Clinical Neuroscience, vol.21, 11, 2014,pp 1847-1856
2014Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendationsBarnett, Michael; Heard, Robert; Parratt, John Douglas; Pollard, John; Reddel, Stephen; Spies, Judith; Boggild, Mike; Brew, B.J. (Bruce); Broadley, Simon; Butzkueven, Helmut; et al, Various; Hodgkinson, Suzanne J.; Kermode, Allan; Lechner-Scott, Jeannette; Macdonell, Richard A.L.; Marriott, Mark; Mason, Deborah F.; Shaw, Cameron P.; Slee, Mark; Taylor, Bruce V.; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineTherapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations, Journal of Clinical Neuroscience, vol.21, 11, 2014,pp 1857-1865